A highly popular class of drugs for diabetes and obesity is showing ... In a mid-stage trial, an older diabetes treatment called lixisenatide helped slow the progression of motor disability ...

Lixisenatide is an older drug in the same class as Novo Nordisk’s big-selling Ozempic/Wegovy (semaglutide), used to treat type 2 diabetes and obesity, as well as to reduce the risk of ...

This belief comes after a mid-stage clinical study suggested that the diabetes medication lixisenatide ... drug is part of a popular group of obesity treatments known as GLP-1 agonists, a class ...